Reimagined and Reinforced: Overcoming the pharma supply chain challenge

As the pharmaceutical industry strives to resolve supply chain challenges brought about by the pandemic, new ones are emerging. Geopolitical issues have increased pressure on supply lines and worsened inflation, resulting in rising costs. A more complex drug development and manufacturing process means the way the supply chain operates has no choice but to evolve, from supplier selection to inventory management to documentation. This paper investigates why it is time for a reconfiguration of the supply chain looking at current issues and latest trends, including recent FDA recommendations, and examines the steps organizations can take to alleviate the burden of supply chain struggles and make the most of this changing market.